Jim Simons's position in Biogen is currently worth $390 Million. That's 0.52% of their equity portfolio (23rd largest holding). The first Biogen trade was made in Q2 2013. Since then Jim Simons bought shares sixteen more times and sold shares on 23 occasions. The stake costed the investor $335 Million, netting the investor a gain of 16% so far.